Atorvastatin Calcium
Product Images NDC 68071-3470

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3470). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3470 6)

Pdp (68071 3470 6)
Atorvastatin Calcium 20 mg tablets packaging label from NuCare Pharmaceuticals, Inc. The label indicates a quantity of 60 tablets per container. Each film-coated tablet contains atorvastatin calcium equivalent to 20 mg atorvastatin, USP. The tablets are described as oval-shaped, white to off-white, with a debossed imprint '114' on one side and plain on the other. The label includes NDC 68071-3470-6 and storage instructions to keep at controlled temperature 68-77°F. It also carries warnings to keep out of reach of children and states the product is Rx only.*
FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 01)

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 01)
Chemical structure diagram of atorvastatin calcium, showing its molecular arrangement including calcium ions and water molecules as part of the structure.*
FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 02)

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 02)
A line chart showing cumulative incidence (%) over 3.5 years comparing Atorvastatin and Placebo groups. The chart indicates lower cumulative incidence for Atorvastatin with a hazard ratio (HR) of 0.64 (0.50-0.83) and a p-value of 0.0005.*
FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 03)

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 03)
A line graph depicting cumulative hazard percentage over a 5-year follow-up period, comparing placebo and atorvastatin groups. The x-axis represents time in years, and the y-axis shows cumulative hazard percentage. The graph includes hazard ratio (HR) and p-value statistics.*
FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 04)

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 04)
A line graph comparing the percentage of subjects experiencing the first major cardiovascular event over time in years for atorvastatin 10 mg and atorvastatin 80 mg. The x-axis represents time to first event in years, and the y-axis represents the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR) of 0.78 with confidence interval (0.69-0.89) and a p-value of 0.0002.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.